Artigo Acesso aberto Revisado por pares

Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy

2001; Wiley; Volume: 88; Issue: 9 Linguagem: Inglês

10.1046/j.1464-4096.2001.00936.x

ISSN

1464-410X

Autores

Yasuhide Miyoshi, Hiroji Uemura, Kazuhisa Kitami, Yoshiaki Satomi, Y. Kubota, Masahiko Hosaka,

Tópico(s)

Peptidase Inhibition and Analysis

Resumo

BJU InternationalVolume 88, Issue 9 p. 982-983 Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy Y. Miyoshi, Y. Miyoshi Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorH. Uemura, H. Uemura Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorK. Kitami, K. Kitami Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorY. Satomi, Y. Satomi Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorY. Kubota, Y. Kubota Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorM. Hosaka, M. Hosaka Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this author Y. Miyoshi, Y. Miyoshi Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorH. Uemura, H. Uemura Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorK. Kitami, K. Kitami Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorY. Satomi, Y. Satomi Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorY. Kubota, Y. Kubota Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this authorM. Hosaka, M. Hosaka Department of Urology, Yokohama City University School of Medicine, JapanSearch for more papers by this author First published: 05 January 2002 https://doi.org/10.1046/j.1464-4096.2001.00936.xCitations: 44 Y. Miyoshi, Department of Urology, Yokohama City University School of Medicine, Fukuura 3–9, Kanazawa-ku, Yokohama, Kanagawa, 236–0004, Japan. e-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Di Sant'Agnese PA. Neuroendocrine differentiation in carcinoma of the prostate. Cancer Suppl 1992; 70: 254–267 10.1002/1097-0142(19920701)70:1+ 3.0.CO;2-E CASPubMedWeb of Science®Google Scholar 2 Abrahamsson PA, Wadstorm LB, Alumets J, Falkmer S, Grimelius L. Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Pathol Res Pract 1986; 181: 675–683 10.1016/S0344-0338(86)80043-7 CASPubMedWeb of Science®Google Scholar Citing Literature Volume88, Issue9December 2001Pages 982-983 ReferencesRelatedInformation

Referência(s)
Altmetric
PlumX